Cover
Cover - shares | 3 Months Ended | |
Sep. 30, 2023 | Nov. 17, 2023 | |
Cover [Abstract] | ||
Entity Registrant Name | Hawkeye Systems, Inc. | |
Entity Central Index Key | 0001750777 | |
Document Type | 10-Q | |
Amendment Flag | false | |
Current Fiscal Year End Date | --06-30 | |
Entity Small Business | true | |
Entity Shell Company | false | |
Entity Emerging Growth Company | false | |
Entity Current Reporting Status | No | |
Document Period End Date | Sep. 30, 2023 | |
Entity Filer Category | Non-accelerated Filer | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2023 | |
Entity Common Stock Shares Outstanding | 5,552,222 | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity File Number | 333-180954 | |
Entity Incorporation State Country Code | NV | |
Entity Tax Identification Number | 83-0799093 | |
Entity Address Address Line 1 | 6605 Abercorn | |
Entity Address Address Line 2 | Suite 204 | |
Entity Address City Or Town | Savannah | |
Entity Address State Or Province | GA | |
Entity Address Postal Zip Code | 31405 | |
City Area Code | 912 | |
Local Phone Number | 253-0375 | |
Entity Interactive Data Current | No |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) | Sep. 30, 2023 | Jun. 30, 2023 |
Current assets: | ||
Cash | $ 50,296 | $ 143,861 |
Prepaid expenses | 13,750 | 2,370 |
Interest receivable | 72,442 | 40,438 |
Loan receivable | 1,275,000 | 800,000 |
Total current assets | 1,411,488 | 986,669 |
Total assets | 1,411,488 | 986,669 |
Current liabilities: | ||
Accounts payable and accrued liabilities - related party | 812,631 | 730,454 |
Accounts payable and accrued liabilities | 28,124 | 13,644 |
Convertible note payable, net of discount - related party | 500,000 | 500,000 |
Accrued interest - related party | 390,568 | 298,158 |
Line of credit - related party | 525,000 | 525,000 |
Promissory note payable - related party | 1,450,000 | 1,000,000 |
Total current liabilities | 3,706,322 | 3,067,256 |
Long-term liabilities: | ||
Loan payable due to Eagle - JV partner | 442,251 | 442,251 |
Total liabilities | 4,148,573 | 3,509,507 |
Stockholders' deficit: | ||
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding | 0 | 0 |
Common stock, $0.0001 par value, 400,000,000 shares authorized; 5,552,222 and 5,552,222 shares issued and outstanding, respectively | 555 | 555 |
Additional paid-in capital | 9,585,094 | 9,585,094 |
Accumulated deficit | (12,322,734) | (12,108,487) |
Total stockholders' deficit | (2,737,085) | (2,522,838) |
Total liabilities and stockholders' deficit | $ 1,411,488 | $ 986,669 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Sep. 30, 2023 | Jun. 30, 2023 |
CONDENSED CONSOLIDATED BALANCE SHEETS | ||
Preferred stock, shares par value | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 50,000,000 | 50,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, shares par value | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 400,000,000 | 400,000,000 |
Common stock, shares issued | 5,552,222 | 5,552,222 |
Common stock, shares outstanding | 5,552,222 | 5,552,222 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Operating expenses: | ||
General and administrative | $ 21,594 | $ 27,755 |
Management compensation | 111,250 | 111,301 |
Professional fees | 35,997 | 20,425 |
Professional fees - related party | 0 | 15,000 |
Total operating expenses | 168,841 | 174,481 |
Loss from operations | (168,841) | (174,481) |
Other income (expense), net: | ||
Other income | 15,000 | 0 |
Interest income | 32,004 | 0 |
Interest expense - related party | (92,410) | (40,615) |
Total other income (expense), net | (45,406) | (40,615) |
Net loss before income taxes provision | (214,247) | (215,096) |
Provision for income tax | 0 | 0 |
Net loss | $ (214,247) | $ (215,096) |
Net loss per common share - basic and diluted | $ (0.04) | $ (0.10) |
Weighted average common shares outstanding - basic and diluted | 5,552,222 | 3,737,915 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS DEFICIT (Unaudited) - USD ($) | Total | Common Stock [Member] | Additional Paid-in Capital [Member] | Accumulated Deficit [Member] |
Balance, shares at Jun. 30, 2022 | 2,560,416 | |||
Balance, amount at Jun. 30, 2022 | $ (2,103,529) | $ 256 | $ 8,778,391 | $ (10,882,176) |
Common stock issued for common stock payable, shares | 1,666,667 | |||
Common stock issued for common stock payable, amount | 594,344 | $ 167 | 594,177 | 0 |
Stock based compensation - options | 5,159 | $ 0 | 5,159 | 0 |
Net loss | (215,096) | (215,096) | ||
Balance, shares at Sep. 30, 2022 | 4,227,083 | |||
Balance, amount at Sep. 30, 2022 | (1,719,122) | $ 423 | 9,377,727 | (11,097,272) |
Balance, shares at Jun. 30, 2023 | 5,552,223 | |||
Balance, amount at Jun. 30, 2023 | (2,522,838) | $ 555 | 9,407,594 | (11,930,987) |
Stock based compensation - options | 0 | |||
Net loss | (214,247) | (214,247) | ||
Balance, shares at Sep. 30, 2023 | 5,552,223 | |||
Balance, amount at Sep. 30, 2023 | $ (2,737,085) | $ 555 | $ 9,407,594 | $ (12,145,234) |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Cash flows from operating activities: | ||
Net loss | $ (214,247) | $ (215,096) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Stock based compensation - options and warrant | 0 | 5,159 |
Change in operating assets and liabilities: | ||
Prepaid expense | (11,381) | (16,702) |
Interest receivable | (32,004) | 0 |
Accounts payable and accrued liabilities | 14,479 | 92,875 |
Accounts payable and accrued liabilities - related party | 82,178 | 0 |
Accrued interest - related party | 92,410 | 0 |
Net cash used in operating activities | (68,565) | (133,764) |
Cash flows from investing activities: | ||
Note receivable from CNTNR | 475,000 | 0 |
Net cash used in investing activities | (475,000) | 0 |
Cash flows from financing activities: | ||
Net proceeds from Promissory note - related party | 450,000 | 0 |
Net proceeds from line of credit | 0 | 160,000 |
Net cash provided by financing activities | 450,000 | 160,000 |
Net change in cash | (93,565) | 26,236 |
Cash beginning of period | 143,861 | 325 |
Cash end of period | 50,296 | 26,561 |
Supplemental cash flow information | ||
Cash paid for interest | 0 | 0 |
Cash paid for taxes | 0 | 0 |
Non-cash investing and financing activities: | ||
Common stock issued exchanged for common stock payable - related party | $ 0 | $ 594,344 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Sep. 30, 2023 | |
Summary of Significant Accounting Policies | |
Summary of Significant Accounting Policies | Note 1 - Summary of Significant Accounting Policies Business Overview Hawkeye Systems, Inc. (the “Company”), is a Nevada corporation incorporated on May 15, 2018. Our previous focus was on pandemic management products and services. From inception and until July of 2021, we focused on selling personal protective equipment (“PPE”). In July 2021, our management determined to cease the Company’s operations as a seller of PPE, deeming that continuing operations in that sector was not a productive use of our resources. Our current business plan is to acquire, merge or consolidate with another company (a “target business”). We intend to use capital stock, debt or a combination of these to effect a business combination with a target business with significant growth potential. While actively searching for a target business, we are concurrently providing management consulting and strategic growth services to CNTNR USA, Inc., a Delaware corporation, to which we have provided a series of loans (see Note 9 “Note Receivable”). Basis of presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2023, as filed with the SEC on October 17, 2023. Use of estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, and the valuation allowance on deferred tax assets. Fair value measurements When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis. Revenue recognition As of September 30, 2023, and 2022, the Company had no revenue. Cost of sales As of September 30, 2023, and 2022, the Company had no cost of sales. Basic and diluted earnings per share Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable with accrued interest. For the three months ended September 30, 2023 and 2022, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows: September 30, September 30, 2023 2022 Warrants 239,401 249,399 Options 425,600 425,600 Convertible notes 672,798 5,227,806 Total possible dilutive shares 1,337,799 5,902,805 Recent accounting pronouncements Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements. In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt-Debt with Conversion and Other Options” and ASC subtopic 815-40 “Hedging-Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company has early adopted this standard effective July 1, 2021 using the modified retrospective approach transition method. |
Going Concern
Going Concern | 3 Months Ended |
Sep. 30, 2023 | |
Going Concern | |
Going Concern | Note 2 - Going Concern The Company’s financial statements are prepared using U.S. GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company’s unaudited condensed consolidated financial statements are prepared using GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. During the three months ended September 30, 2023, the Company had a net loss of $214,247, and had an accumulated deficit of $12,322,734 as of September 30, 2023. The Company has not established sufficient revenue to cover its operating costs and will require additional capital to continue its operating plan. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt about its ability to continue as a going concern. In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company include: sales of equity instruments; traditional financing, such as loans; and obtaining capital from management and significant stockholders sufficient to meet its minimum operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing this plan. There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. |
Loan payable due to Eagle - JV
Loan payable due to Eagle - JV partner | 3 Months Ended |
Sep. 30, 2023 | |
Loan payable due to Eagle - JV partner | |
Loan payable due to Eagle - JV partner | Note 3 – Loan payable due to Eagle - JV partner July 17, 2020, the Company entered into a membership agreement with Eagle Equities LLC (“Eagle”) and Ikon Supplies (“Ikon”) to form a Nevada Limited Liability Company, HIE, LLC (“HIE”) for the purpose of procuring, funding the purchase of and sale of PPE (the “Membership Agreement”). Subject to the provision of the Membership Agreement, the interest of any net profits would be shared 33.3% among each member. If there is a loss in some or all of the capital, the Company is contingently liable to contribute to repay 33.3% of the Origination Loan and Additional Contribution and of any losses of HIE. In addition, the Company is obliged to repay 1/3 of the loan contributed by Eagle or 1/3 of the capital paid by Eagle according to the Membership Agreement. HIE did not have any operating activities since July 2021. As a result, the Company’s investment balance in HIE as of September 30, 2023 was $0, and the loan balance payable to joint venture partner Eagle totaled $442,251, unchanged for two years. |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Sep. 30, 2023 | |
Related Party Transactions | |
Related Party Transactions | Note 4 - Related Party Transactions Related party transactions are described in detail in Note 5, Note 6, Note 7, Note 8, and Note 10. |
Inventory Financing Payable - r
Inventory Financing Payable - related party | 3 Months Ended |
Sep. 30, 2023 | |
Inventory Financing Payable - related party | |
Inventory Financing Payable - related party | Note 5 – Inventory Financing Payable – related party On February 19, 2021, Steve Hall, a shareholder of the Company, advanced $1 million to the Company. The purpose of the advance was to purchase inventory to satisfy customer orders. The advance would be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction. The terms of the agreement are non-interest bearing. The creditor is 100% at risk as this is a non-recourse funding vehicle. In June 2021 the Company cancelled the contemplated purchase of inventory and returned $500,000 to Mr. Hall. Mr. Hall agreed to allow the Company to retain the balance to fund future purchases and general operating expenses. On October 1, 2021, the Company and Steve Hall entered into a restated and amended promissory note, to consolidate and restate the terms pursuant to which Steve Hall had provided funds to the Company (the “Consolidated Note”). The Consolidated Note consolidated and restated the terms of advances made on February 17, 2021, for $500,000 for inventory financing, February 18, 2021, for $500,000 for inventory financing, November 12, 2021, for $30,000 and December 13, 2021, for $75,000. In addition to consolidating the advances singled out above, the Consolidated Note included the extension of a line of credit of up to $1,000,000, from Steve Hall to the Company. The principal amount of the Consolidated Note, excluding the $1,000,000 line of credit, is $1,105,000, payable on demand at any time after October 1, 2022 (the “Due Date”), and accruing interest at a rate of 12% per year, if repaid within 90 days of the due date and 20% if repaid thereafter. Principal and interest due under the line of credit extended pursuant to the Consolidated Note shall be added to the principal amount due under the Consolidated Note and shall be payable pursuant to the same terms. The line of credit is due and payable on the Due Date unless extended. At the option of holder, the Consolidated Note is convertible, at any time, into shares of common stock at a conversion price of $0.02 per share. The Consolidated Note’s Due Date was extended to September 30, 2023 and we have not received any notice from Steve Hall indicating his intention to collect or convert the principal and interest under the Consolidated Note. As of September 30, 2023, and 2022, the accrued interest under the Consolidated Note was $190,137, and $90,137, and the principal balance was $500,000 at the end of both years, respectively. |
Line of Credit related party
Line of Credit related party | 3 Months Ended |
Sep. 30, 2023 | |
Line of Credit related party | |
Line of Credit - related party | Note 6 – Line of Credit – related party On October 1, 2021, Steve Hall agreed to provide a line of credit of up to $1,000,000 to the Company with simple interest at a rate of 12% for the first 90 days, and simple interest at a rate of 20% per annum thereafter. All principal disbursed under the line of credit will accrue interest, and be payable on the same terms as principal due under the Consolidated Note (see Note 6). The line of credit expired on October 1, 2022. Subsequently, the line of credit has been orally renewed and extended with same terms and a new maturity date of October 1, 2023. As of September 30, 2023, and 2022, the outstanding principal of the line of credit totaled $525,000, and $425,000, with accrued interest balances of $130,460, and $30,424, respectively. |
Promissory notes payable - rela
Promissory notes payable - related party | 3 Months Ended |
Sep. 30, 2023 | |
Promissory notes payable - related party | |
Promissory notes payable - related party | Note 7 – Promissory Notes Payable – related party On March 29, 2023, Steve Hall provided the Company with a loan in the principal amount of $1,000,000, as evidenced by a promissory note with an annual interest rate of 12% per year (the “Steve Hall Note”). The purpose of the Steve Hall Note was to provide the Company with a funding source to make a follow-on investment in CNTNR USA, Inc., a Delaware corporation (“CNTNR”). On May 31, 2023 (or upon the closing of a debt financing), the Company will repay the outstanding principal balance of the Steve Hall Note to Steve Hall and transfer to him 90% of the shares of CNTNR, issued by CNTNR to the Company pursuant to the Company’s investment in CNTNR, plus 90% of the CNTNR Warrants as described below in Note 9 - Note Receivable. As of September 30, 2023, the outstanding loan balance was $1,450,000 with accrued interest of $69,972. the Steve Hall Note is past its maturity date. The Company is currently working with Mr. Hall to restructure the note and extend its maturity date. |
Accrued expenses - related part
Accrued expenses - related party | 3 Months Ended |
Sep. 30, 2023 | |
Accrued expenses - related party | |
Accrued expenses - related party | Note 8 – Accrued Expenses – related party Between September 2021 to September 2022, the Company had accepted deposits in the total amount of $33,218 from Central National Gottesman, Inc., on a sale of face masks on behalf of Steve Hall, a shareholder of Hawkeye Systems, Inc. As of September 30, 2023, the deposits remain with the Company and have not been sent to Mr. Hall. In addition, there are no fixed repayment terms or any repayment arrangement on this accrued liability. |
Note receivable
Note receivable | 3 Months Ended |
Sep. 30, 2023 | |
Note receivable | |
Note receivable | Note 9 – Note Receivable On February 27, 2023, the Company and CNTNR USA, Inc. (“CNTNR”) entered into a promissory note under which the Company disbursed $200,000 to CNTNR (the “CNTNR Note”). Subsequently, on April 6, 2023, the Company and CNTNR amended and restated the CNTNR Note (the “Amended CNTNR Note”). In the Amended CNTNR Note, the Company agreed to lend CNTNR the total principal amount of $1,000,000 (“Principal Amount”) with a commitment fee equivalent to 5% of the Principal Amount. CNTNR further agreed to pay the Company a monthly consulting fee of $5,000 beginning on March 1, 2023 that will continue until the Principal Amount is repaid. In exchange for the consulting fee, the Company will provide management consulting and strategic growth services to CNTNR. The balance of the consulting fee is recorded as an accounts receivable. As of September 30, 2023, the accounts receivable has a zero balance. The Amended CNTNR Note has an annual interest rate of 12% and matures at the earlier of September 30, 2023, or the closing of a material debt or equity financing. Upon maturity of the Amended CNTNR Note, CNTNR will pay to the Company all outstanding Principal Amount and interest, plus any outstanding consulting fee and issue the Company 10% of the issued and outstanding shares of CNTNR (equivalent to 6,170,879 shares). Moreover, the Amended CNTNR Note includes warrant coverage of one warrant for every share issued in repayment of the Principal Amount at the closing of an intended merger with CNTNR which is equal to 6,170,879 warrants. The warrants will have a 30% discount rate to the current fair market price of the shares of CNTNR when exercised and will expire 36 months after April 6, 2023. Both the shares and warrant shares have not been issued as of September 30, 2023 and will be recorded at fair value as financing income upon issuance at settlement. The interest is calculated on the total balance of the available loan of $1,000,000 starting on the date of the first transfer on February 28, 2023. As of September 30, 2023, the CNTNR Note and the Amended CNTNR Note have accrued interest of $72,442 with an outstanding principal of $1,275,000. The increase in the principal amount from $1,000,000 to $1,275,000 is due to the Company extending an additional loan of $275,000 to CNTNR on the same terms and conditions those of the Amended CNTNR Note. The parties are currently working on amending the Amended CNTNR Note to reflect the increase on the principal amount of such nore. |
Consulting Agreement - Related
Consulting Agreement - Related Party | 3 Months Ended |
Sep. 30, 2023 | |
Consulting Agreement - Related Party | |
Consulting Agreement - Related Party | Note 10 – Consulting Agreement Related Party On January 30, 2023, Hawkeye entered into a consulting agreement with Steve Hall, a shareholder of the Company, to provide real estate and development consulting services, including the supervision of the Company’s senior management, staff and all personnel, whether employees or consultants, strategic planning, property acquisitions and annual budget review. The contract period is 12 months with no option for renewal thereafter. The Company has paid Steve Hall a one-time flat service fee of $250,000 on January 31, 2023. Compensation is without recourse and there is no requirement for performance of services during the term of the contract. |
Stockholders Equity
Stockholders Equity | 3 Months Ended |
Sep. 30, 2023 | |
Stockholders Equity | |
Stockholders' Equity | Note 11 - Stockholders’ Equity Stock Purchase Warrants Transactions in stock purchase warrants for the three months ended September 30, 2023 are as follows: Number of Warrants Weighted Average Exercise Price Balance at June 30, 2023 239,401 $ 1.04 Expired - - Balance at September 30, 2023 239,401 $ 1.04 The composition of the Company’s warrants outstanding at September 30, 2023 are as follows: Exercise Price Number of Warrants Weighted Average Remaining Life (in years) $ 0.30 35,000 0.58 $ 0.50 66,667 0.58 $ 1.00 70,867 0.58 $ 2.00 66,867 0.58 239,401 0.58 The intrinsic value of the warrants as of September 30, 2023 was $0. Stock Options Transactions in stock options for the three months ended September 30, 2023 are as follows: Weighted Weighted average Number of average remaining life options exercise price (in years) Outstanding, June 30, 2023 425,600 $ 1.41 3.41 Granted - - - Cancelled - - - Exercised - - - Outstanding, September 30, 2023 425,600 1.41 3.16 Exercisable, September 30, 2023 425,600 $ 1.41 3.16 During the three months ended September 30, 2023, the Company had not granted any stock options. And all stock options were vested at the fiscal year end June 30, 2023. At September 30, 2023, the intrinsic value of the outstanding options was $0. |
Stock Reverse Split
Stock Reverse Split | 3 Months Ended |
Sep. 30, 2023 | |
Stock Reverse Split | |
Stock Reverse Split | Note 12 – Stock Reverse Split Hawkeye filed a form of 8K/A on March 23, 2023 announcing the Company amended its Articles of Incorporation to effect a one-for-ten reverse stock split (the “Reverse Split”) of the Company’s common stock while par value of $0.0001 per share remain the same. The Reverse Split was approved by FINRA on February 8, 2023, and became effective on February 9, 2023. All fractional shares resulting from the Reverse Split were rounded up to the nearest whole share, which results in an additional 139 shares issued for rounding. As a result of the Reverse Split, the Company had 4,227,222 shares of common stock issued and outstanding on February 8, 2023. In addition, at the effective time of the Reverse Split, all common shares, warrants, options and the related financial information as filed in the Quarterly Report on Form 10-Q of 3 rd |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Sep. 30, 2023 | |
Commitments and contingencies (Note -13) | |
Commitments and Contingencies | Note 13 – Commitments and Contingencies On July 17, 2020, the Company entered into a Membership Agreement with Eagle and Ikon to form HIE. Under the terms and conditions of the Membership Agreement, in the event of a loss of capital of HIE, the Company shall contribute to repay 33.3% of the Origination Loan and Additional Contribution and of any losses of HIE. HIE did not have operating activities during the quarter ended September 30, 2023. Detailed discussions are included in Note 3 – Loan payable due to Eagle - JV partner. On January 30, 2023, Hawkeye entered into a consulting agreement with Steve Hall, a shareholder of the Company, to provide real estate and development consulting services. Transactions are described in detail in Note 10 - Consulting Agreement - Related Party . On February 27, 2023, the Company and CNTNR USA, Inc. (“CNTNR”) entered into a promissory note under which the Company disbursed $200,000 to CNTNR (the “CNTNR Note”). Subsequently, on April 6, 2023, the Company and CNTNR amended and restated the CNTNR Note (the “Amended CNTNR Note”) of which the Company agreed to lend CNTNR the total principal amount of $1,000,000 (“Principal Amount”) with a commitment fee equivalent to 5% of the Principal Amount. Detailed discussions are included in Note 9 - Note Receivable. |
Subsequent Events
Subsequent Events | 3 Months Ended |
Sep. 30, 2023 | |
Subsequent Events | |
Subsequent Events | Note 14 - Subsequent Events Management has evaluated subsequent events through the date of these financial statements were available to be issued. Based on our evaluation no material events have occurred that require disclosure. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Sep. 30, 2023 | |
Summary of Significant Accounting Policies | |
Business Overview | Hawkeye Systems, Inc. (the “Company”), is a Nevada corporation incorporated on May 15, 2018. Our previous focus was on pandemic management products and services. From inception and until July of 2021, we focused on selling personal protective equipment (“PPE”). In July 2021, our management determined to cease the Company’s operations as a seller of PPE, deeming that continuing operations in that sector was not a productive use of our resources. Our current business plan is to acquire, merge or consolidate with another company (a “target business”). We intend to use capital stock, debt or a combination of these to effect a business combination with a target business with significant growth potential. While actively searching for a target business, we are concurrently providing management consulting and strategic growth services to CNTNR USA, Inc., a Delaware corporation, to which we have provided a series of loans (see Note 9 “Note Receivable”). |
Basis of presentation | The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed consolidated financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2023, as filed with the SEC on October 17, 2023. |
Use of estimates | The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, and the valuation allowance on deferred tax assets. |
Fair value measurements | When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis. |
Revenue recognition | As of September 30, 2023, and 2022, the Company had no revenue. |
Cost of sales | As of September 30, 2023, and 2022, the Company had no cost of sales. |
Basic and diluted earnings per share | Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable with accrued interest. For the three months ended September 30, 2023 and 2022, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows: September 30, September 30, 2023 2022 Warrants 239,401 249,399 Options 425,600 425,600 Convertible notes 672,798 5,227,806 Total possible dilutive shares 1,337,799 5,902,805 |
Recent Accounting Pronouncements | Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements. In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt-Debt with Conversion and Other Options” and ASC subtopic 815-40 “Hedging-Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company has early adopted this standard effective July 1, 2021 using the modified retrospective approach transition method. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Summary of Significant Accounting Policies | |
Schedule Of potentially dilutive common stock | September 30, September 30, 2023 2022 Warrants 239,401 249,399 Options 425,600 425,600 Convertible notes 672,798 5,227,806 Total possible dilutive shares 1,337,799 5,902,805 |
Stockholders Equity (Tables)
Stockholders Equity (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Stockholders Equity | |
Schedule of transactions in stock purchase warrants | Number of Warrants Weighted Average Exercise Price Balance at June 30, 2023 239,401 $ 1.04 Expired - - Balance at September 30, 2023 239,401 $ 1.04 |
Schedule of warrants outstanding | Exercise Price Number of Warrants Weighted Average Remaining Life (in years) $ 0.30 35,000 0.58 $ 0.50 66,667 0.58 $ 1.00 70,867 0.58 $ 2.00 66,867 0.58 239,401 0.58 |
Schedule Of Transactions in stock options | Weighted Weighted average Number of average remaining life options exercise price (in years) Outstanding, June 30, 2023 425,600 $ 1.41 3.41 Granted - - - Cancelled - - - Exercised - - - Outstanding, September 30, 2023 425,600 1.41 3.16 Exercisable, September 30, 2023 425,600 $ 1.41 3.16 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Details) - shares | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Convertible Note [Member] | ||
Total possible dilutive shares | 672,798 | 5,227,806 |
Options [Member] | ||
Total possible dilutive shares | 425,600 | 425,600 |
Total Possible Dilutive Shares [Member] | ||
Total possible dilutive shares | 1,337,799 | 5,902,805 |
Warrant [Member] | ||
Total possible dilutive shares | 239,401 | 249,399 |
Going Concern (Details Narrativ
Going Concern (Details Narrative) - USD ($) | 3 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Jun. 30, 2023 | |
Going Concern | |||
Net loss | $ (214,247) | $ (215,096) | |
Accumulated deficit | $ (12,322,734) | $ (12,108,487) |
Loan payable due to Eagle - J_2
Loan payable due to Eagle - JV partner (Details Narrative) - USD ($) | 1 Months Ended | ||
Jul. 17, 2020 | Sep. 30, 2023 | Sep. 30, 2022 | |
Description of membership agreement | the Company is obliged to repay 1/3 of the loan contributed by Eagle or 1/3 of the capital paid by Eagle | ||
Loan Payable | $ 442,251 | $ 442,251 | |
Profit sharing for each member, percentage | 33.30% | ||
HIE [Member] | |||
Investment in HIE | $ 0 | $ 0 | |
Percentage of contingent liablility to repay origination loan and additional contribution | 33.30% |
Inventory Financing Payable rel
Inventory Financing Payable related party (Details Narrative) - USD ($) | 1 Months Ended | 12 Months Ended | |||||
Oct. 01, 2021 | Feb. 19, 2021 | Jun. 30, 2021 | Sep. 30, 2023 | Mar. 29, 2023 | Feb. 27, 2023 | Sep. 30, 2022 | |
Inventory Financing Payable related party (Details Narrative) | |||||||
Advances from related party | $ 1,000,000 | ||||||
Related party transaction description | The purpose of the advance was to purchase inventory to satisfy customer orders. The advance would be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction. The terms of the agreement are non-interest bearing. The creditor is 100% at risk as this is a non-recourse funding vehicle | ||||||
Repayment to related party | $ 500,000 | ||||||
Description Of Business | February 17, 2021, for $500,000 for inventory financing, February 18, 2021, for $500,000 for inventory financing, November 12, 2021, for $30,000 and December 13, 2021, for $75,000. In addition to consolidating the advances singled out above, the Consolidated Note included the extension of a line of credit of up to $1,000,000, from Steve Hall to the Company. The principal amount of the Consolidated Note, excluding the $1,000,000 line of credit, is $1,105,000, payable on demand at any time after October 1, 2022 (the “Due Date”), and accruing interest at a rate of 12% per year, if repaid within 90 days of the due date and 20% if repaid thereafter | ||||||
Common stock shares conversion price | $ 0.02 | ||||||
Accrued interest | $ 190,137 | $ 90,137 | |||||
Principal amount | $ 500,000 | $ 1,000,000 | $ 1,000,000 |
Line of Credit related party (D
Line of Credit related party (Details Narrative) - USD ($) | Oct. 01, 2021 | Sep. 30, 2023 | Sep. 30, 2022 |
Outstanding line of credit | $ 525,000 | $ 425,000 | |
Accrued interest payable | $ 130,460 | $ 30,424 | |
On October 1, 2021 | Line of credit related party description | Steve Hall [Member] | |||
Line of credit related party description | agreed to provide a line of credit of up to $1,000,000 to the Company with simple interest at a rate of 12% for the first 90 days, and simple interest at a rate of 20% per annum thereafter | ||
Expiry date of line of credit | October 1, 2023 |
Promissory notes payable - re_2
Promissory notes payable - related party (Details Narrative) - USD ($) | 1 Months Ended | 3 Months Ended | |
Mar. 29, 2023 | Sep. 30, 2023 | Feb. 27, 2023 | |
Principal amount | $ 1,000,000 | $ 500,000 | $ 1,000,000 |
Annual interest rate of loan | 12% | ||
Note repayment terms, description | the Company will repay the outstanding principal balance of the Steve Hall Note to Steve Hall and transfer to him 90% of the shares of CNTNR, issued by CNTNR to the Company pursuant to the Company’s investment in CNTNR, plus 90% of the CNTNR Warrants | ||
Accrued interest related party | $ 69,972 | ||
Promissory Note [Member] | |||
Principal amount | $ 1,450,000 |
Accrued expenses - related pa_2
Accrued expenses - related party (Details Narrative) | 13 Months Ended |
Sep. 30, 2022 USD ($) | |
Hawkeye Systems, Inc [Member] | |
Accepted deposits | $ 33,218 |
Note receivable (Details Narrat
Note receivable (Details Narrative) - USD ($) | 1 Months Ended | 3 Months Ended | ||
Feb. 28, 2023 | Feb. 27, 2023 | Sep. 30, 2023 | Mar. 29, 2023 | |
Principal amount | $ 1,000,000 | $ 500,000 | $ 1,000,000 | |
Advanced payment | $ 200,000 | |||
Commitment fees rate | 5% | |||
CNTNR [Member] | ||||
Principal amount | $ 1,000,000 | 6,170,879 | ||
Advanced payment | $ 200,000 | |||
Commitment fees rate | 5% | |||
Monthly consulting fee | 5,000 | |||
Annual interest rate | 12% | |||
Maturity date | Sep. 30, 2023 | |||
Discripiton of warrants discount | The warrants will have a 30% discount rate to the current fair market price of the shares of CNTNR when exercised and will expire 36 months after April 6, 2023 | |||
Accrued interest | $ 72,442 | |||
Interest amount | $ 1,000,000 | |||
Description of Extending Additional Loan | The increase in the principal amount from $1,000,000 to $1,275,000 is due to the Company extending an additional loan of $275,000 to CNTNR on the same terms and conditions those of the Amended CNTNR Note | |||
Amended CNTNR [Member] | ||||
Principal amount | $ 1,275,000 |
Consulting Agreement - Relate_2
Consulting Agreement - Related Party (Details Narrative) | 1 Months Ended |
Jan. 31, 2023 USD ($) | |
Consulting Agreement [Member] | |
Service fee | $ 250,000 |
Stockholders Equity (Details)
Stockholders Equity (Details) - Stock Purchase Warrants [Member] | 3 Months Ended |
Sep. 30, 2023 USD ($) $ / shares shares | |
Warrant shares, Beginning | shares | 239,401 |
Warrant shares, Expired | $ | $ 0 |
Warrant shares, Ending | shares | 239,401 |
Weighted average exercise price, Beginning | $ 1.04 |
Weighted average exercise price, Expired | 0 |
Weighted average exercise price, Ending | $ 1.04 |
Stockholders Equity (Details 1)
Stockholders Equity (Details 1) | 3 Months Ended |
Sep. 30, 2023 $ / shares shares | |
Warrants outsanding 1 [Member] | |
Exercise Price | $ / shares | $ 0.30 |
Number of Warrants | 35,000 |
Weighted Average Remaining Life (in years) | 6 months 29 days |
Warrants outsanding 2 [Member] | |
Exercise Price | $ / shares | $ 0.50 |
Number of Warrants | 66,667 |
Weighted Average Remaining Life (in years) | 6 months 29 days |
Warrants outsanding 3 [Member] | |
Exercise Price | $ / shares | $ 1 |
Number of Warrants | 70,867 |
Weighted Average Remaining Life (in years) | 6 months 29 days |
Warrants outsanding 4 [Member] | |
Exercise Price | $ / shares | $ 2 |
Number of Warrants | 66,867 |
Weighted Average Remaining Life (in years) | 6 months 29 days |
Warrants outsanding [Member] | |
Number of Warrants | 239,401 |
Weighted Average Remaining Life (in years) | 6 months 29 days |
Stockholders Equity (Details 2)
Stockholders Equity (Details 2) - Stock Options [Member] | 3 Months Ended |
Sep. 30, 2023 $ / shares shares | |
Number of options, beginning balance | shares | 425,600 |
Number of options, ending balance | shares | 425,600 |
Number of options, Exercisable | shares | 425,600 |
Weighted Average Exercise Price, beginning balance | $ / shares | $ 1.41 |
Weighted Average Exercise Price, ending balance | $ / shares | 1.41 |
Weighted Average Exercise Price, Exercisable | $ / shares | $ 1.41 |
Weighted average remaining life, beginning | 3 years 4 months 28 days |
Weighted average remaining life, ending | 3 years 1 month 28 days |
Weighted average remaining life, exercisable | 3 years 1 month 28 days |
Stockholders Equity (Details Na
Stockholders Equity (Details Narrative) | Sep. 30, 2023 USD ($) |
Warrant [Member] | |
Intrinsic value of the outstanding options | $ 0 |
Stock Options [Member] | |
Intrinsic value of the outstanding options | $ 0 |
Stock Reverse Split (Details Na
Stock Reverse Split (Details Narrative) - $ / shares | 3 Months Ended | |
Sep. 30, 2023 | Jun. 30, 2023 | |
Common stock par value | $ 0.0001 | $ 0.0001 |
Common stock, shares outstanding | 5,552,222 | 5,552,222 |
Stock Reverse Split [Member] | ||
Common stock par value | $ 0.0001 | |
Common stock, shares outstanding | 4,227,222 | |
Description of stock reverse split | The Reverse Split was approved by FINRA on February 8, 2023, and became effective on February 9, 2023. All fractional shares resulting from the Reverse Split were rounded up to the nearest whole share, which results in an additional 139 shares issued for rounding |
Commitments and Contingencies (
Commitments and Contingencies (Details Narrative) - USD ($) | 1 Months Ended | 3 Months Ended | |
Feb. 27, 2023 | Sep. 30, 2023 | Mar. 29, 2023 | |
Commitments and contingencies (Note -13) | |||
Origination Loan | 33.30% | ||
Principal amount | $ 1,000,000 | $ 500,000 | $ 1,000,000 |
Advanced payment | $ 200,000 | ||
Commitment fees rate | 5% |